Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report) shares were up 7.4% during mid-day trading on Wednesday . The stock traded as high as $6.44 and last traded at $6.44. Approximately 1,000 shares changed hands during trading, a decline of 84% from the average daily volume of 6,218 shares. The stock had previously closed at $5.9966.
Analyst Ratings Changes
Separately, Zacks Research upgraded Oxford BioMedica to a “hold” rating in a research report on Wednesday, July 22nd. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Hold”.
Read Our Latest Stock Analysis on Oxford BioMedica
Oxford BioMedica Stock Performance
Oxford BioMedica Company Profile
Oxford BioMedica plc is a United Kingdom-based contract development and manufacturing organization (CDMO) focused on cell and gene therapies. The company helps biotechnology and pharmaceutical customers develop, test, and manufacture advanced therapies, with expertise in viral-vector technologies used to deliver genetic material into cells.
Its services include process and analytical development, clinical and commercial manufacturing, quality testing, regulatory support, and related research services.
See Also
- Five stocks we like better than Oxford BioMedica
- Full Throttle: Kratos and GE Fire Up a Next-Gen Defense Engine
- Sandisk Joins the S&P 100—Is the Index Flow, or the AI Story, Driving the Stock?
- These 4 Companies Are Monetizing AI Today
- Quantum and Rare Earths? Implications of the Pasqal/USAR Partnership
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
